pemafibrate
Kowa Pharmaceuticals
['vte']
#prominent at #aha22 : pemafibrate reduced tg, remnant c, apo-c3, increased ldl-c and apob, no effect on 1 composite endpoint. significant risk of renal events and vte. 
Cardiologist + researcher @MGHHeartHealth. Preventive cardiology, women's health, pregnancy, health policy. Tweets are my own. He/him.